Maria Jaine A. Sipin

Maria Jaine A. Sipin serves as a key procurement specialist within the Defense Health Agency, supporting the agency’s mission to deliver secure, high-quality healthcare services to uniformed personnel, retirees, and their families. She manages acquisitions critical to operational readiness, focusing on pharmaceutical manufacturing and specialized clinical support services. Her work ensures the timely procurement of essential medical supplies and infrastructure, aligning with DHA’s strategic priorities in pharmaceutical supply chain resilience and clinical workflow modernization. Sipin handles competitive and set-aside contracts under federal acquisition regulations, ensuring compliance with DoD procurement standards while maintaining rigorous oversight of contract performance and delivery timelines. Sipin maintains consistent working relationships with a select group of contractors including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These partnerships reflect a blend of niche pharmaceutical manufacturers, medical technology providers, and specialized service vendors supporting clinical operations and health data integrity. Her procurement approach emphasizes vendor reliability, regulatory compliance, and technical capability, fostering long-term collaborations with firms that meet stringent DoD quality and security benchmarks. Her contracting patterns reveal a balanced commitment to socioeconomic programs, with 50% of her awards designated for 8(a) competed set-asides and the remainder awarded without set-aside status. This reflects a deliberate strategy to promote small business participation while maintaining flexibility to source mission-critical capabilities from qualified large and small entities. Sipin actively leverages the 8(a) program to cultivate emerging defense contractors with expertise in healthcare logistics and pharmaceutical distribution. Her primary procurement focus centers on NAICS 325412 (Pharmaceutical Preparation Manufacturing) and NAICS 541219 (Other Accounting Services), indicating a dual emphasis on securing FDA-compliant medications and specialized financial oversight for clinical programs. This combination underscores her technical expertise in managing complex, regulated procurements that intersect pharmaceutical supply chains with administrative infrastructure essential to DHA’s operational health systems.